Allarity Therapeutics, Inc. Cash and Cash Equivalents
Allarity Therapeutics, Inc. (ALLR) had Cash and Cash Equivalents of $16.98 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $16.98M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $19.81M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $14.69M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $16.89M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $16.98M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $19.81M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $14.69M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $16.89M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $17.80M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $25.20M 10-Q · filed 2026-05-15 |
| 2024-12-31 | $19.53M 10-K · filed 2026-03-30 |
| 2024-06-30 | $19.23M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $312.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $166.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.40M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $420.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $295.00K 10-Q · filed 2024-05-14 |
| 2022-12-31 | $2.03M 10-K · filed 2024-03-08 |
| 2022-09-30 | $3.95M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $7.68M 10-Q · filed 2023-08-14 |
| 2021-09-30 | $5.58M 10-Q · filed 2021-11-23 |
| 2020-12-31 | $298.00K 10-Q · filed 2021-11-23 |
| 2020-09-30 | $30.00K 10-Q · filed 2021-11-23 |
| 2019-12-31 | $1.52M 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |